A <info type="DiseaseOrPhenotypicFeature">Type 2 Diabetes</info>-Associated Functional Regulatory <info type="SequenceVariant">Variant</info> in a <info type="OrganismTaxon">Pancreatic Islet</info> <info type="GeneOrGeneProduct">Enhancer</info> at the <info type="GeneOrGeneProduct">ADCY5</info> <info type="GeneOrGeneProduct">Locus</info>.

Molecular mechanisms remain unknown for most <info type="DiseaseOrPhenotypicFeature">type 2 diabetes</info> genome-wide association study identified loci. <info type="SequenceVariant">Variants</info> associated with <info type="DiseaseOrPhenotypicFeature">type 2 diabetes</info> and <info type="DiseaseOrPhenotypicFeature">fasting glucose levels</info> reside in introns of <info type="GeneOrGeneProduct">ADCY5</info>, a <info type="GeneOrGeneProduct">gene</info> that encodes <info type="GeneOrGeneProduct">adenylate cyclase 5</info>. <info type="GeneOrGeneProduct">Adenylate cyclase 5</info> catalyzes the production of <info type="ChemicalEntity">cyclic AMP</info>, which is a second messenger molecule involved in cell signaling and <info type="OrganismTaxon">pancreatic b-cell</info> <info type="GeneOrGeneProduct">insulin</info> <info type="GeneOrGeneProduct">secretion</info>. We demonstrated that <info type="DiseaseOrPhenotypicFeature">type 2 diabetes</info> risk alleles are associated with decreased <info type="GeneOrGeneProduct">ADCY5</info> expression in <info type="OrganismTaxon">human islets</info> and examined candidate <info type="SequenceVariant">variants</info> for regulatory function. <info type="SequenceVariant">rs11708067</info> overlaps a predicted <info type="GeneOrGeneProduct">enhancer region</info> in <info type="OrganismTaxon">pancreatic islets</info>. The <info type="DiseaseOrPhenotypicFeature">type 2 diabetes</info> risk <info type="SequenceVariant">rs11708067-A allele</info> showed fewer <info type="GeneOrGeneProduct">H3K27ac ChIP-seq</info> reads in <info type="OrganismTaxon">human islets</info>, lower transcriptional activity in reporter assays in <info type="OrganismTaxon">rodent b-cells</info> (<info type="OrganismTaxon">rat 832/13</info> and <info type="OrganismTaxon">mouse MIN6</info>), and increased nuclear protein binding compared with the <info type="SequenceVariant">rs11708067-G allele</info>. Homozygous deletion of the orthologous <info type="GeneOrGeneProduct">enhancer region</info> in <info type="CellLine">832/13 cells</info> resulted in a 64% reduction in expression level of <info type="GeneOrGeneProduct">Adcy5</info>, but not adjacent <info type="GeneOrGeneProduct">gene</info> <info type="GeneOrGeneProduct">Sec22a</info>, and a 39% reduction in <info type="GeneOrGeneProduct">insulin secretion</info>. Together, these data suggest that <info type="SequenceVariant">rs11708067-A risk allele</info> contributes to <info type="DiseaseOrPhenotypicFeature">type 2 diabetes</info> by disrupting an <info type="OrganismTaxon">islet enhancer</info>, which results in reduced <info type="GeneOrGeneProduct">ADCY5</info> expression and impaired <info type="GeneOrGeneProduct">insulin secretion</info>.